Literature DB >> 10570091

Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis.

C K Farmer1, G J Cook, G M Blake, J Reidy, J E Scoble.   

Abstract

BACKGROUND: Atherosclerotic renovascular disease is increasingly recognized as an important cause of renal failure in patients over 60 years of age but the processes leading to renal dysfunction have not been defined. We have examined the relationship between renal artery stenosis and individual renal function in patients with atherosclerotic renal artery stenosis.
METHODS: In this prospective descriptive study over a 25-month period, we examined the relationship between the presence of renal artery stenosis and single kidney glomerular filtration rate (SKGFR). SKGFR was measured using a novel method of synchronous (51)Chromium ethylenediamine tetraacetic acid glomerular filtration rate ((51)CrEDTA-GFR) and (99m)Technetium dimercaptosuccinic acid ((99m)TcDMSA) scintigraphy. We studied 79 patients with a mean age of 68.9 years (25.2-88.2), 44 males and 35 females. The mean age of the males was 70 years (60-80) and females 67 years (25.2-88.2).
RESULTS: We found that the precision of the SKGFR was 2 ml/min. For paired kidneys we found: (i) no significant difference between kidneys with stenosis (17.3 ml/min) compared to those without stenosis (13.6 ml/min) (P=0.22); (ii) kidneys with occluded renal arteries had significantly less function (2.6 ml/min) than those without occlusion (24.5 ml/min) (P<0.05). When degree of renal arteries stenosis was correlated with SKGFR there was a reduction with an increasing degree of stenosis (<30% 27 ml/min, 30-60% 17.7 ml/min, >60% stenosis 15 ml/min, P=0. 016).
CONCLUSIONS: These data demonstrate that SKGFR provides a reproducible measure of individual kidney function. There was a similar impairment of function in paired kidneys with and without renal artery stenosis, but occlusion was associated with significant reduction in function compared to the contralateral kidney. This suggests that there is a process causing renal dysfunction in patients with atherosclerotic disease independent of renal artery narrowing.

Entities:  

Mesh:

Year:  1999        PMID: 10570091     DOI: 10.1093/ndt/14.12.2880

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 2.  Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death.

Authors:  John Main
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Hypertension and reduced renal function in an 83-year-old patient.

Authors:  Andrea Ungar; Lorella Lambertucci; Chiara Agresti; Riccardo Pini; Maria Boddi; Maria Consuelo Valentini; Gianfranco Parati; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 4.  [Renal artery stenosis. Pathophysiology--diagnosis--therapy].

Authors:  Heinrich Wieneke; Thomas Friedrich Michael Konorza; Holger Eggebrecht; Christoph Kurt Naber; Sebastian Philipp; Thomas Philipp; Andreas Kribben; Raimund Erbel
Journal:  Med Klin (Munich)       Date:  2009-05-16

5.  [Ischemic renal disease and renal artery stenosis].

Authors:  T Lenz
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

Review 6.  Diagnosis and treatment of renal artery stenosis.

Authors:  Pierre-François Plouin; Liesbeth Bax
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

7.  Management of renal artery stenosis - an update.

Authors:  A Alhadad
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

8.  The outcome of kidney transplant from living donors with pelvi-ureteric junction dysfunction.

Authors:  Miroslav Tisljar; Hatem Ali; Charlie Gledhill-Flynn; Mila Garreus; Arvind Ponnusamy; Aimun Ahmed
Journal:  Int Urol Nephrol       Date:  2020-06-10       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.